110 related articles for article (PubMed ID: 21040991)
1. The metabolic response using 18F-fluorodeoxyglucose-positron emission tomography/computed tomography and the change in the carcinoembryonic antigen level for predicting response to pre-operative chemoradiotherapy in patients with rectal cancer.
Yoon MS; Ahn SJ; Nah BS; Chung WK; Song JY; Jeong JU; Nam TK
Radiother Oncol; 2011 Jan; 98(1):134-8. PubMed ID: 21040991
[TBL] [Abstract][Full Text] [Related]
2. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.
Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH
Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012
[TBL] [Abstract][Full Text] [Related]
3. PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer.
Kristiansen C; Loft A; Berthelsen AK; Graff J; Lindebjerg J; Bisgaard C; Jakobsen A
Dis Colon Rectum; 2008 Jan; 51(1):21-5. PubMed ID: 17975715
[TBL] [Abstract][Full Text] [Related]
4. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
5. Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations.
Kyoto Y; Momose M; Kondo C; Itabashi M; Kameoka S; Kusakabe K
Ann Nucl Med; 2010 Jun; 24(5):395-401. PubMed ID: 20364373
[TBL] [Abstract][Full Text] [Related]
6. Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer.
Guerra L; Niespolo R; Di Pisa G; Ippolito D; De Ponti E; Terrevazzi S; Bovo G; Sironi S; Gardani G; Messa C
Abdom Imaging; 2011 Feb; 36(1):38-45. PubMed ID: 20033405
[TBL] [Abstract][Full Text] [Related]
7. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
9. The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer.
Lambrecht M; Deroose C; Roels S; Vandecaveye V; Penninckx F; Sagaert X; van Cutsem E; de Keyzer F; Haustermans K
Acta Oncol; 2010 Oct; 49(7):956-63. PubMed ID: 20586658
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
[TBL] [Abstract][Full Text] [Related]
11. Response to preoperative short-course radiotherapy in locally advanced rectal cancer: value of f-fluorodeoxyglucose positron emission tomography.
Siegel R; Dresel S; Koswig S; Gebauer B; Hunerbein M; Schneider W; Schlag PM
Onkologie; 2008 Apr; 31(4):166-72. PubMed ID: 18418017
[TBL] [Abstract][Full Text] [Related]
12. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck.
Zimmer LA; Branstetter BF; Nayak JV; Johnson JT
Laryngoscope; 2005 Nov; 115(11):2029-34. PubMed ID: 16319618
[TBL] [Abstract][Full Text] [Related]
13. [Lung cancer detected by fluorodeoxyglucose-positron emission tomography/computed tomography in the course of Mycobacterium avium infection; report of a case].
Adachi K; Kaneda M; Sakai T; Fujimoto H; Ibata H; Omoto Y; Watanabe F
Kyobu Geka; 2009 Oct; 62(11):1019-21. PubMed ID: 19827559
[TBL] [Abstract][Full Text] [Related]
14. [Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ?].
Kobayashi N; Fujita K; Fujisawa T; Takahashi H; Yoneda M; Abe Y; Inamori M; Kirikoshi H; Kubota K; Saito S; Nakajima A
Gan To Kagaku Ryoho; 2008 Jan; 35(1):65-70. PubMed ID: 18195530
[TBL] [Abstract][Full Text] [Related]
15. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level.
Lee JH; Park SG; Jee KN; Park DG; Namgung H; Song IH
Nucl Med Commun; 2010 Jun; 31(6):576-82. PubMed ID: 20216474
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET provides the best correlation with the tumor specimen compared to MRI and CT in rectal cancer.
Buijsen J; van den Bogaard J; Janssen MH; Bakers FC; Engelsman S; Öllers M; Beets-Tan RG; Nap M; Beets GL; Lambin P; Lammering G
Radiother Oncol; 2011 Feb; 98(2):270-6. PubMed ID: 21295874
[TBL] [Abstract][Full Text] [Related]
18. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
[TBL] [Abstract][Full Text] [Related]
19. 18F-FLT-PET for detection of rectal cancer.
Muijs CT; Beukema JC; Widder J; van den Bergh AC; Havenga K; Pruim J; Langendijk JA
Radiother Oncol; 2011 Mar; 98(3):357-9. PubMed ID: 21295872
[TBL] [Abstract][Full Text] [Related]
20. Assessment of metabolic response to pre-operative treatment of rectal cancer.
Abu Zallouf S; El-Sherify MS; Fayaz S
Gulf J Oncolog; 2010 Jul; (8):59-66. PubMed ID: 20601343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
